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This consensus paper provides a framework for grading of severity of cardiovascular magnetic resonance (CMR)
imaging-based assessment of chamber size, function, and aortic measurements. This does not currently exist for
CMR measures. Differences exist in the normal reference values between echocardiography and CMR along with
differences in methods used to derive these. We feel that this document will significantly complement the current
literature and provide a practical guide for clinicians in daily reporting and interpretation of CMR scans. This manu-
script aims to complement a recent comprehensive review of CMR normal value publications to recommend cut-
off values required for severity grading. Standardization of severity grading for clinically useful CMR parameters is
encouraged to lead to clearer and easier communication with referring clinicians and may contribute to better pa-
tient care. To this end, the European Association of Cardiovascular Imaging (EACVI) has formed this expert panel
that has critically reviewed the literature and has come to a consensus on approaches to severity grading for com-
monly quantified CMR parameters.
...................................................................................................................................................................................................
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Introduction
Cardiovascular magnetic resonance (CMR) imaging is now
firmly established in clinical practice as a cardiac imaging modality,
which complements other non-invasive techniques, such as
echocardiography, nuclear cardiac imaging, and cardiac computed
tomography (CT). CMR has an important role in a wide range of clin-
ical indications and scenarios.1–3
Patient impact is dependent on the quality of the clinical CMR
service provision. Efforts to standardize CMR image acquisition,4,5
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CMR image analysis and CMR image reporting contribute to raising
overall CMR service quality.6 Certification of individuals in CMR sets
minimum standards of expertise and provides evidence to those that
can demonstrate it.7
Communication of CMR and other imaging modality findings is a
key component to ensure that they positively impact patient manage-
ment.8 Complementing a description of a parameter as being normal
or abnormal (reference values), clinical imaging physicians most often
qualify the extent of abnormalities using terms such as ‘mild’, ‘moder-
ate’, or ‘severe’. Such descriptions allow the clinician not only to
understand that the parameter is abnormal but also the extent to
which their patient’s measurements deviate from normal. As well as
providing normative data it would be beneficial to standardize cut-
offs for severity of abnormality across centres, such that moderately
abnormal has the same implication in all. The association of continu-
ous information with prognosis may be stronger than between the
categories of normal, mildly, moderately, and severely abnormal and
prognosis.9 However, communication of the degree of abnormality
in categories may be clearer to the referring physician and thus may
lead to more rapid and consistent clinical decisions.
For CMR measurements, there is no consensus on how to categor-
ize the severity of abnormality. The echocardiography community has
published consensus statements to this end.10,11 Here, we attempt to
suggest approaches to grade the severity of abnormality for common
and clinically useful CMR parameters. Recommendations on image
analysis, including chamber quantification, have been published and
are not the scope of this paper.6 Readers of this expert consensus art-
icle should ensure they are aware of the analysis methods used for
the original data from which the normal reference ranges are derived,
as different analysis approaches can have a clinically relevant impact
on results. Between CMR and other imaging modalities that can meas-
ure the same phenotype systemic biases may exist. Using the same
cut-off values based on different modalities may thus not always be
appropriate and even using the same cut-off values for different CMR
techniques needs to be interpreted with caution, given documented
differences (e.g. between fast gradient echo and steady-state free pre-
cession for myocardial mass and volumes).12
The authors acknowledge explicitly that the same value on a con-
tinuous scale or the same category may not reflect the same degree
of abnormality depending on the context. Despite a normal left ven-
tricular ejection fraction (LVEF) value in the context of severe mitral
regurgitation, this may still suggest an abnormal systolic function.
Similarly, a patient with severe concentric hypertrophy and a ‘normal’
LVEF may still have abnormal systolic function. Thus, any attempt to
categorize the severity of abnormality should not be seen as providing
optimal cut-off values in every case. Physicians reporting CMR scans
should provide an interpretation that considers the clinical context.
Methodology for severity grading
The writing group considered several different approaches to define
the cut-off values for mild, moderate, and severely abnormal meas-
urements. Multiple statistical techniques exist for determining thresh-
old values, all of which have limitations.13 The first approach would
be to define these cut-offs for abnormalities based on standard devia-
tions below and above the normal reference limit derived from a
group of healthy subjects. These data exist for most CMR parame-
ters. However, not all cardiac parameters are normally distributed,
such as aortic valve regurgitant fraction, making the use of standard
deviation as a measure of spread potentially problematic.
The second approach would be to define abnormalities based on
percentile values (95th, 99th, etc.) of measurements. These are
derived from a population that would include normal subjects along
with individuals with disease states.14 They would consider asymmet-
ric distribution and range of abnormality present within the general
population. A limiting factor for this approach is that large enough
population data sets do not exist for most CMR variables. Ideally, an
approach could classify outcomes directly. A moderately abnormal
variable would imply a moderate risk of a particular adverse outcome
for that patient. Risk data are still sparse for some CMR measures
and a moderate degree of deviation from normal may have differen-
tial effects on different important outcomes (e.g. morbidity and mor-
tality). The third approach defines cut-off values based on expert
opinion. Although scientifically least rigorous, this method considers
the collective experience of a panel of experienced CMR experts.
We used expert consensus mainly when the statistical methods
would not provide equally distributed value ranges between the se-
verity categories and to provide some consistency if well-established
cut-offs exist for other imaging modalities (e.g. LVEF grading).
Despite the limitations, this categorization of CMR parameters in the
abnormal range represents another step towards the standardization
of clinical CMR complementing the consensus documents on CMR
image acquisition, interpretation and analysis, and reporting.4,6,15
Derived parameter values could be automatically categorized in clin-
ical reporting software or clinical trials for improved interpretation of
CMR results.
In the following sections, we present consensus suggestions on the
grading severity of abnormality based on the anatomical structure
assessed. We do not attempt to provide values for each normal ref-
erence paper that exists at the time of publication. Specifically, this
consensus paper complements a comprehensive recent systematic
review of normal ranges using CMR.16 Much of what is presented in
this paper is derived from published normal ranges with relatively
small samples but can be updated in the future, using the same princi-
ples, with larger datasets. For example, it would also be ideal to have
reference ranges categorized by age as well as gender. However, be-
cause of the small number of individuals included in the current stud-
ies, the consensus was to delay providing age categorized grading
until larger reference ranges are published. This will hopefully provide
more accurate ranges. We did not include the recent UK Biobank
reference ranges in this consensus document given that the LVEFs
were significantly lower than currently accepted normal ranges.17
Further analysis of the data was considered to be required by the
writing group before recommending its use in routine clinical prac-
tice. It should also be noted that recent European Society of
Cardiology heart failure guidelines now categorize heart failure
patients as those having reduced (<40%), mid-range (40–49%), and
preserved (>50%) ejection fraction based on transthoracic echocar-
diographic measures.18
Most of the normal range publications did not specify the ethnicity
but were derived from a western population and would largely if not
all have been Caucasians and predominantly from the UK.19–25 The
approaches here are mostly defining cut-off values based on standard


























































deviations reported in the normal population apart from ejection
fraction measurement that are derived from a combination of stand-
ard deviation and expert consensus. Using the statistical method, the
normal range is defined as ±2 SD from the mean, mildly abnormal
from this cut-off to 3 SD, moderately abnormal from the mild cut-off
to 4 SD, and severe being more than 4 SD from the population mean.
The term ‘Opposite’ refers to values that are outside the normal
range but in the opposite direction of typical thought of as pathology,
e.g. smaller LV end-diastolic volumes or supra-normal LVEF. This
consensus agreement was to allow commonly used cut-offs that are
used for different imaging modalities and avoid confusion. It should
be emphasized that these cut-offs are to allow clearer and easier
communication of grading. As such, any new or omitted reference
range can easily be categorized using the same principles.
Measurements and methods
The summary of measurements and techniques used in deriving the
normal values from the published papers that are included in this con-
sensus paper are included in Table 1 with description of the method-
ology used in the relevant subsections. Table 2 provided additional
details of the individual studies used to derive the grading parameters.
Grading suggestions for left ventricular (Table 3), right ventricular
(Table 4), left atrial (LA, Table 5), right atrial (RA, Table 6), and aortic
parameters (Table 7), based mainly on a recent review containing
normal ranges, are provided.16
Left and right ventricular ejection
fraction
Ejection fraction of the left ventricle is one of the most commonly
used cardiac imaging parameters in clinical practice. LVEF and right
ventricular ejection fraction grades were decided on using a com-
bination of statistical method and consensus consistent with the
method used by the European Association of Cardiovascular
Imaging (EACVI) echocardiography recommendations.11 Normal
range was based on statistical method (published mean ±2 SD).
Mildly reduced systolic function was based on a combination
of statistical method (for upper range, mean minus 2 SD) and
consensus (for lower range). Grading for moderate and severely
reduced left ventricular systolic function was based on consensus
between the group and in line with the cut-offs published in the
EACVI echocardiography document.11
Normalizing or indexing the reference values according to body
habitus can be done in many different ways, most commonly values
are indexed to body surface area. The principles of categorizing
abnormal values to mildly, moderately, or severely abnormal are in-
dependent of the indexing approach.
Left and right atria
We would ideally recommend using volume assessment rather
than the areas for the atria for increased accuracy. However,
there are some discrepancies in the normal reference values for
LA volume between some studies and this should be considered
when interpreting the results.19,21 As 3D analysis tools are not
readily available and may be more time consuming, our current
recommendation would be to use the biplane method of disks/
area analysis based on 2D images from four- and two-chamber
views. There is need for a future update of the grading cut-offs for
LA and RA volumes with larger reference range studies. In the
meantime, we have still included the LA area measurements.
Similar caution in interpretation should be used when assessing
....................................................................................................................................................................................................................
Table 1 Summary of measurements and techniques used in the normal values published papers included in this con-
sensus paper
Parameter/method Technique Advantages Limitations
LV mass and volumes19,20
(Figure 1)
Papillary muscles included in the mass and
excluded from the volumes (Figure 1)
More accurate assessment of
mass
More time consuming. Often not
followed in clinical practice
RV mass and volumes19,20
(Figure 1)
Papillary muscles included in the mass and
excluded from the volumes (Figure 1)
More accurate assessment of
mass
More time consuming
LA volumes19 (Figure 2) Biplane area–length method in HLA and VLA.
LA appendage included in LA area but not
PVs (Figure 2)
Available from standard imag-
ing SSFP
Not as accurate as SAX contours or
3D analysis
LA volumes21 3D modelling, including tracking of AV ring. At
phase in which LA size maximal. LA append-
age included in LA area but not PVs
More accurate than biplane
area–length method
Requires 3D modelling software for
SSFP image analysis
RA volumes22 (Figure 3) 3D modelling, including tracking of AV ring and
time volume curves. At phase in which RA
size maximal.
More accurate than area–
length method (Figure 3)




SSFP images endo-endo from oblique coronal
and oblique sagittal views in late diastole
(Figure 4)
Accurate assessment of aortic
dimensions in 2D
Requires ECG gating. Not as accur-
ate as 3D assessment
2D, 2-dimensional; 3D, 3-dimensional; AV, atrioventricular; ECG, electrocardiogram; HLA, horizontal long axis; LA, left atrium; LV, left ventricle; PV, pulmonary vein; RA, right
atrium; RV, right ventricle; SAX, short axis; SSFP, steady-state free precession; VLA, vertical long axis.















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RA volume measurements as discrepancies also exist for normal
reference range values for the RA. This is likely in part due to the
assumptions made when using the equations to derive volume
measurements from a single four-chamber view.
It should be noted that echo assessment predominantly uses
the area–length method or the modified Simpson’ rule (Figure 2).
Differences in volumes from 3D CMR measures and from
echo will exist due to different techniques, spatial resolution and
from the inclusion of the appendages in the volumes measured
by CMR. For these reasons, care should be taken to avoid
direct comparison of measurements and cut-offs obtained
from CMR and echo.
Aortic root indices
Although the proposed acquisition method is relatively simple, cor-
rect alignment of the oblique sagittal and coronal imaging planes may
be difficult and ensuring reliable measurements can be challenging, as
applied in the study of Burman et al.25 A 3D steady-state free preces-
sion (SSFP) or a contrast-enhanced magnetic resonance angiography
(MRA) may be the more appropriate method for ensuring precise
........................................................................................ ........................................................................................
....................................................................................................................................................................................................................





















EDV (mL) <86 86–178 179–201 202–224 >224 <106 106–214 215–241 242–268 >268 SM
EDV /BSA
(mL/m2)
<56 56–96 97–106 107–116 >116 <57 57–105 106–117 118–129 >129 SM
ESV (mL) <22 22–66 67–77 78–88 >88 <26 26–82 83–96 97–110 >110 SM
ESV/BSA
(mL/m2)b
<14 14–34 35–39 40–44 >44 <14 14–38 39–44 45–50 >50 SM
EF (%) >78 57–77 41–56 30–40 <30 >78 57–77 41–56 30–40 <30 SM, EC
Mass (g) <56 56–140 141–161 162–182 >182 <92 92–176 177–197 198–218 >218 SM
Mass/BSA
(g/m2)
<41 41–81 82–91 92–101 >101 <49 49–85 86–94 95–103 >103 SM
‘Opposite’ refers to values that outside the normal range but in the opposite direction of typical pathology, e.g. smaller LV end-diastolic volumes or supra-normal LV ejection
fraction.
BSA, body surface area; EC, expert consensus; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricular; SM, statistical method.
aCombined values from references Alfakih et al.24 (30 males:30 females), Hudsmith et al.19 (63 males:45 females), Maceira et al.20 (60 males:60 females), and unless stated
otherwise.
bFrom references Hudsmith et al.19 (63 males:45 females) and Maceira et al.20 (60 males:60 females) only.
....................................................................................... ........................................................................................
....................................................................................................................................................................................................................





















EDV (mL) <77 77–201 202–232 233–263 >263 <118 118–250 251–283 284–316 >316 SM
EDV /BSA
(mL/m2)
<48 48–112 113–128 129–144 >144 <61 61–121 122–136 137–151 >151 SM
ESV (mL) <24 24–84 85–99 100–114 >114 <41 41–117 118–136 137–155 >155 SM
ESV/BSA
(mL/m2)b
<12 12–52 53–62 63–72 >72 <19 19–59 60–69 70–79 >79 SM
EF (%) >71 51–71 41–51 30–40 <30 >72 52–72 41–52 30–40 <30 SM, EC
Mass (g)b <21 21–49 50–56 57–63 >63 <25 25–57 58–65 66–73 >73 SM
Mass/BSA
(g/m2)b
<12 12–28 29–32 33–36 >36 <13 13–29 30–33 34–37 >37 SM
‘Opposite’ refers to values that outside the normal range but in the opposite direction of typical pathology, e.g. smaller LV end-diastolic volumes or supra-normal LV ejection
fraction;
BSA, body surface area; EC, expert consensus; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; RV, right ventricular; SM, statistical method.
aCombined values from references Alfakih et al.,24 (30 males:30 females), Hudsmith et al.19 (63 males:45 females).
bFrom reference Hudsmith et al. (63 males:45 females) only.























measurements. However, further studies are needed to validate the
most accurate and reproducible method of measuring the aorta using
CMR and other imaging modalities. Previous guidelines recom-
mended that maximum aneurysm diameter be ideally measured per-
pendicular to the centre line of the vessel with 3D reconstruction of
CT scan images whenever possible. This approach appears to offer
more accurate and reproducible measurements of true aortic dimen-
sions compared with axial cross-section diameters. Using sagittal and
coronal views in CMR can provide a good estimation of aortic
measurements but may be inaccurate in measuring the true max-
imum diameters in cases where asymmetry exists.
Limitations
The measures for grading are based on currently available normal
ranges. These are based on relatively small cohorts of healthy volun-
teers and there may be some variations between published reference
ranges. Utilizing the methodology outlined in this consensus paper
................................................................................. .................................................................................
....................................................................................................................................................................................................................
Table 5 Left atrial maximal volume in the adult based on 3D modelling method and left atrial maximal area in the























<38 38–98 99–113 114–128 >128 <47 47–107 108–122 123–137 >137 SM
Max. LA volume/BSA
(mL/m2)
<27 27–53 54–60 61–67 >67 <26 26–52 53–59 60–66 >66 SM
Adults
Area (cm2) 4Ch <13 13–27 28–31 32–35 >35 <15 15–29 30–33 34–37 >37 SM
Area/BSA
(cm2/m2) 4Ch
<8.4 8.4–15.6 15.7–17.4 17.5–19.2 >19.2 <7.4 7.4–14.6 14.7–16.4 16.5–18.2 >18.2 SM
Area (cm2) 2Ch <10 10–28 29–33 34–38 >38 <12 12–30 31–35 36–40 >40 SM
Area/BSA
(cm2/m2) 2Ch
<6.2 6.2–15.8 15.9–18.2 18.3–20.6 >20.6 <6.2 6.2–15.8 15.9–18.2 18.3–20.6 >20.6 SM
Area (cm2) 3Ch <10 10–24 25–28 29–31 >31 <12 12–26 27–30 31–33 >33 SM
Area/BSA (cm2/m2) 3Ch <6.4 6.4–13.6 13.7–15.4 15.5–17.2 >17.2 <6.4 6.4–13.6 13.7–15.4 15.5–17.2 >17.2 SM
‘Opposite’ refers to values that outside the normal range but in the opposite direction of typical pathology.
2Ch, two-chamber view; 3Ch, three-chamber view; 4Ch, four-chamber view; BSA, body surface area; LA, left atrium; Max, maximum; SM, statistical method; SSFP, steady-state
free precession.
aFrom reference according to reference Maceira 2010 (60 males:60 females) only.21
................................................................................................................................
....................................................................................................................................................................................................................
Table 6 Right atrial maximal volume and right atrial maximal area in the adult for the SSFP technique based on













Max. RA volume (mL)a <37 37–169 170–202 203–235 >235 SM
Max. RA volume/BSA (mL/m2)a <18 18–90 91–108 109–126 >126 SM
20–80 years
Area (cm2) 4Chb <14 14–30 31–34 35–38 >38 SM
Area/BSA (cm2/m2) 4Chb <8 8–16 17–18 19–20 >20 SM
Area (cm2) 2Chb <14 14–30 31–34 35–38 >38 SM
Area/BSA (cm2/m2) 2Chb <8 8–16 17–18 19–20 >20 SM
‘Opposite’ refers to values that outside the normal range but in the opposite direction of typical pathology.
2Ch, two-chamber view; 4Ch, four-chamber view; BSA, body surface area; Max, maximum; Min, minimum; RA, right atrium; SM, statistical method; SSFP, steady-state free
precession.
aFrom reference Seivers 2007 (38 males:32 females) only.27
bFrom reference Maceira 2013 (60 males:60 females) only.22







aging/advance-article-abstract/doi/10.1093/ehjci/jez232/5572609 by guest on 24 Septem
ber 2019
Figure 1 Short-axis slices including left ventricular endocardial and epicardial contours and right ventricular endocardial contours. The four- and
two-chamber views show the full coverage of the left and right ventricles required for analysis.
.................................................................................. ..................................................................................
....................................................................................................................................................................................................................





















Annulus (s) (mm) <16. 16–23 24–25 26–28 >28 <17 17–27 28–29 30–32 >32 SM
Annulus (c) (mm) <19 19–27 28–29 30–32 >32 <21 21–30 31–33 34–36 >36 SM
Aortic sinus(s) (mm) <22 22–35 36–39 40–42 >42 <24 24–40 41–45 46–50 >50 SM
Aortic sinus(c) (mm) <24 24–36 37–40 41–43 >43 <25 25–42 43–47 48–52 >52 SM
STJ (s) (mm) <18 18–30 31–33 34–36 >36 <17 17–33 34–37 38–42 >42 SM
STJ (c) (mm) <18 18–28 29–31 32–34 >34 <18 18–32 33–36 37–40 >40 SM
c, coronal left ventricular outflow plane; F, female; M, male; s, sagittal left ventricular outflow plane; SM, statistical method; STJ, sinotubular junction.
aFrom reference Burman 2008 (60 males:60 females) only.25





























































we plan to update this consensus paper using normal ranges of larger
cohorts, such as from the UK Biobank study, once further validation
work has been completed in order to provide more robust reference
ranges. Reference values for LV volumes and mass are influenced by
gender and age and thus were presented separately in reference range
paper, however, given the small sample sizes in the age categorized
tables, we considered it would be more accurate to provide age cate-
gorized grading parameters derived from larger data sets in the future.
Indexed measurements may present limitations when
considering obese patients, as the increase in chambers volumes/
dimensions is not necessarily proportional to the increase in
body surface area and may thus lead to inconsistencies.
Unfortunately, this is a common problem for a number of
imaging modalities and is not unique to CMR. Ideally, the cut-offs
for severity categorization using CMR and other imaging modal-
ities should be linked with their impact on the outcomes.
However, data regarding this are currently limited. Direct com-
parison in large cohorts with echocardiography should be done
in the future since CMR and echo measures are not directly
comparable (different techniques, different measurements’
methods) and cut-offs may not be the same when considering
severity categorization. This will have obvious clinical impact
such as when deciding on suitability for advanced cardiac device
therapy e.g. cardiac resynchronization therapy or implantable
cardioverter-defibrillators.
Aortic measurements may be more accurately determined using
more advanced CMR techniques (e.g. 3D high resolution non-
contrast native MRA with high isotropic resolution); also, the studies
quoted were published before the Society for Cardiovascular
Magnetic Resonance (SCMR) 2013 Standardized image interpret-
ation and post-processing in CMR paper,6 so could introduce some
variability in measurements reported between the studies quoted,
and contemporary practices.
The normal ranges for right ventricular end-diastolic volumes
indexed to body surface area using the contemporary SSFP cine
imaging approach contain the cut-off values for major or minor crite-
ria as part of the arrhythmogenic right ventricular cardiomyopathy
(ARVC) task force criteria.28 The ARVC task force criteria were
developed largely based on gradient echo cine CMR which is known
to underestimate volumes due to lower/incomplete endocardial bor-
der definition.12,29 Arguably, the ARVC Task Force criteria may need
updating based on contemporary SSFP cine normal ranges provided
in this expert consensus document to avoid being too sensitive or
lacking specificity.
Figure 2 Left atrial contours for area assessment in four and two chambers during atrial end-diastole, measures just before the mitral valve opening
for maximum LA volume.
Figure 3 Right atrial contour for area–length measurement dur-
ing atrial end-diastole for maximal RA volume.
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Figure 4 Oblique sagittala (A and B) and oblique coronalb (C and D) left ventricular outflow views showing the common aortic root measurements.
Typically, annulus measured during systole and sinuses of Valsalva and sinotubular junction measured in diastole.11,26
aOblique coronal acquisitions were then located orthogonal to the oblique sagittal cine, aligned with the axis of the left ventricular outflow tract.25
bOblique sagittal images were obtained by aligning orthogonal to the coronal scouts in the axis of the left ventricular outflow tract and proximal
ascending aorta.
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